Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Cirrhosis

  Free Subscription


1 BMC Gastroenterol
1 Clin Res Hepatol Gastroenterol
5 Dig Dis
1 Dig Dis Sci
1 J Gastroenterol
1 J Gastroenterol Hepatol
3 J Hepatol
2 PLoS One
1 Transplant Proc
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Gastroenterol

  1. SIMON TG, Hagstrom H, Sharma R, Soderling J, et al
    Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
    BMC Gastroenterol. 2021;21:439.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  2. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
    The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.
    Clin Res Hepatol Gastroenterol. 2021 Nov 20:101838.
    PubMed         Abstract available

    Dig Dis

  3. SHAO X, Uojima H, Arai T, Ogawa Y, et al
    The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.
    Dig Dis. 2021 Nov 22. pii: 000521062. doi: 10.1159/000521062.
    PubMed         Abstract available

  4. PARK J, Lee EY, Li J, Jun MJ, et al
    NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
    Dig Dis. 2021;39:634-645.
    PubMed         Abstract available

  5. FREITAS M, Macedo Silva V, Xavier S, Magalhaes J, et al
    Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Dig Dis. 2021;39:653-662.
    PubMed         Abstract available

  6. ATTA S, Kamel M, Mansour W, Hussein T, et al
    Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool.
    Dig Dis. 2021;39:534-539.
    PubMed         Abstract available

  7. KUSNIK A, Hunter N, Rasbach E, Miethke T, et al
    Co-Medication and nutrition in HCC: Potentially preventative strategies in Hepatocellular carcinoma (HCC).
    Dig Dis. 2021 Jan 11. pii: 000514277. doi: 10.1159/000514277.
    PubMed         Abstract available

    Dig Dis Sci

  8. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed         Abstract available

    J Gastroenterol

  9. ITAKURA J, Kurosaki M, Setoyama H, Simakami T, et al
    Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis.
    J Gastroenterol. 2021;56:470-478.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  10. GAZELAKIS K, Mendis S, Wang S, Wong S, et al
    Hepatobiliary and Pancreatic: Liver lesions in cirrhosis: When to biopsy?
    J Gastroenterol Hepatol. 2021 Nov 22. doi: 10.1111/jgh.15735.

    J Hepatol

  11. WONG F, Piano S, Angeli P
    Reply to: Correspondence on "Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure".
    J Hepatol. 2021;75:1010-1012.

  12. BETTINGER D, Thimme R, Schultheiss M
    Reply: TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01891.

  13. RUDLER M, Savier E, Alioua I, Sultanik P, et al
    TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 May 26. pii: S0168-8278(21)00347.

    PLoS One

  14. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed         Abstract available

  15. WANG Y, Xiao X, Wang X, Guo F, et al
    Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis.
    PLoS One. 2021;16:e0258194.
    PubMed         Abstract available

    Transplant Proc

  16. KUBO M, Gotoh K, Kobayashi S, Iwagami Y, et al
    Modified Cavoportal Hemitransposition for Severe Portal Vein Thrombosis Contributed to Long-term Survival After Deceased Donor Liver Transplantation-Insight Into Portal Modulation for Improving Survival: A Case Report.
    Transplant Proc. 2021 Jul 9. pii: S0041-1345(21)00445.
    PubMed         Abstract available

    Z Gastroenterol

  17. LABENZ C, Kostev K, Galle PR, Worns MA, et al
    Prescription rates of common medications in patients with decompensated cirrhosis in Germany.
    Z Gastroenterol. 2021 Nov 24. doi: 10.1055/a-1676-4822.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.